Cyclooxygenase-2 (COX-2) - A Therapeutic Target in Liver Cancer?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 32, 2007-11 ,pp. : 3305-3315

Bentham Science Publishers

Access to resources Recommend Favorite

Cycloxygenase-2 (COX-2) - A Potential Target for Screening of Small Molecules as Radiation Countermeasure Agents: An In Silico Study

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 1, 2013-03 ,pp. : 35-45

Bentham Science Publishers

Access to resources Recommend Favorite

Chebulagic Acid Synergizes the Cytotoxicity of Doxorubicin in Human Hepatocellular Carcinoma Through COX-2 Dependant Modulation of MDR-1

By  

Medicinal Chemistry, Vol. 7, Iss. 5, 2011-09 ,pp. : 432-442

Bentham Science Publishers

Access to resources Recommend Favorite

Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 931-937

Bentham Science Publishers

Access to resources Recommend Favorite

Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2

By Roth Patrik   Hammer Caroline   Piguet Anne-Christine   Ledermann Monika   Dufour Jean-François   Waelti Ernst  

Journal of Drug Targeting, Vol. 15, Iss. 9, 2007-11 ,pp. : 623-631

Informa Healthcare

Access to resources Recommend Favorite